Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models. - Lim SM; Yang SD; Lim S; Heo SG; Daniel S; Markovets A; Minoo R; Pyo KH; Yun MR; Hong MH; Kim HR; Cho BC (Therapeutic advances in medical oncology, 2022)